Risk factors for gastrointestinal tract colonization with extended-spectrum β-actamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients

Infection Control and Hospital Epidemiology

Volumn 33, Issue 12, 2012, Pages 1242-1245

  Han, Jennifer H ^a   Nachamkin, Irving ^a   Zaoutis, Theoklis E ^a,b   Coffin, Susan E ^a,b   Linkin, Darren R ^a,c   Fishman, Neil O ^a   Weiner, Mark G ^a   Hu, Baofeng ^a   Tolomeo, Pam ^a   Lautenbach, Ebbing ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CLINDAMYCIN; CORTICOSTEROID; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SURVEILLANCE; DISK DIFFUSION; DRUG EXPOSURE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GASTROINTESTINAL TRACT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; KLEBSIELLA; KLEBSIELLA INFECTION; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARRIER STATE; CASE-CONTROL STUDIES; CLINDAMYCIN; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL TRACT; HUMANS; KLEBSIELLA; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; RECTUM; RISK FACTORS; THIENAMYCINS;

EID: 84869187022     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/668443     Document Type: Article

References (10)

1. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006;50:1257-1262.
2. Pena C, Pujol M, Ricart A, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β-lac-tamase (ESBL-KP) in the intensive care unit. JHosp Infect 1997; 35:9-16.
3. Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol 2004;25:838-841.
4. Friedmann R, Raveh D, Zartzer E, et al. Prospective evaluation of colonization with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009;30:534-542.
5. Reddy P, Malczynski M, Obias A, et al. Screening for extended-spectrum β-actamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 2007;45:846-852.
6. Harris AD, McGregor JC, Johnson JA, et al. Risk factors for colonization with extended-spectrum β-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007; 13:1144-1149.
7. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. CLSI document M100-S20. Wayne, PA: CLSI, 2010.
8. Mc Gettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH. Prevalence of CTX-M β-lactamases in Philadelphia, Pennsylvania. J Clin Microbiol 2009;47:2970-2974.
9. Tumbarello M, Sanguinetti M, Montuori E, et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. An-timicrob Agents Chemother 2007;51:1987-1994.
10. Song KH, Jeon JH, Park WB, et al. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC Infect Dis 2009;9: 41.